PAMCX
Price
$94.06
Change
-$3.25 (-3.34%)
Updated
Dec 18 closing price
SMXAX
Price
$17.76
Change
-$2.90 (-14.04%)
Updated
Dec 18 closing price
Ad is loading...

PAMCX vs SMXAX

Header iconPAMCX vs SMXAX Comparison
Open Charts PAMCX vs SMXAXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$94.06
Change-$3.25 (-3.34%)
VolumeN/A
CapitalizationN/A
SEI Extended Market Index A (SIIT)
Price$17.76
Change-$2.90 (-14.04%)
VolumeN/A
CapitalizationN/A
PAMCX vs SMXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAMCX vs. SMXAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and SMXAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.4B vs. SMXAX (1.19B). SMXAX pays higher dividends than PAMCX: SMXAX (1.10) vs PAMCX (0.00). PAMCX was incepted earlier than SMXAX: PAMCX (25 years) vs SMXAX (12 years). SMXAX is a more actively managed with annual turnover of: 34.00 vs. PAMCX (21.70). PAMCX has a lower initial minimum investment than SMXAX: PAMCX (2500) vs SMXAX (100000). SMXAX annual gain was more profitable for investors over the last year : 24.87 vs. PAMCX (3.76). SMXAX return over 5 years is better than : 35.39 vs. PAMCX (6.33).
PAMCXSMXAXPAMCX / SMXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years12 years-
Gain YTD2.42122.78311%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.19B2,650%
Annual Yield % from dividends0.001.10-
Returns for 1 year3.7624.8715%
Returns for 3 years-10.3912.22-85%
Returns for 5 years6.3335.3918%
Returns for 10 years31.7378.5140%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEMD0.370.02
+5.75%
Aethlon Medical
CNM51.99-0.92
-1.74%
Core & Main
TGLS81.24-3.32
-3.93%
Tecnoglass
CAPR13.20-0.68
-4.90%
Capricor Therapeutics
ELVA2.15-0.25
-10.42%
Electrovaya